Efficacy of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease (NCT06919081) | Clinical Trial Compass
RecruitingPhase 2
Efficacy of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease
United States24 participantsStarted 2025-08-01
Plain-language summary
In this phase II randomized double-masked clinical trials, subjects with non-resolving corneal epithelial disease/defect (i.e., refractory to standard treatments for at least two weeks) will receive 8 weeks treatment of topical mesenchymal stem cell secretome or vehicle, with continued follow-up for up to Day 70.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age · Patients 18 years of age or older
* Ocular Health
* Chronic corneal epithelial disease with fluorescein staining score 6 by NEI grading scale or persistent corneal epithelial defect present for longer than 14 days despite standard treatment
* No objective clinical evidence of significant (\> 50%) improvement/worsening of the epithelial disease in the last 14 days
* Epithelial disease refractory to conventional non-surgical treatments (e.g., preservative-free artificial tears, gels or ointments; discontinuation of preserved topical drops; anti-inflammatory therapy)
* If both eyes of subject meet the inclusion criteria, the eye with the higher fluorescein staining score will be enrolled to the study.
* Study Procedures
* Only patients who satisfy all Informed Consent requirements may be included in the study. The patient and/or his/her legal representative must read, sign and date the Informed Consent document before any study-related procedures are performed. The Informed Consent form signed by patients and/or legal representative must have been approved by the UIC IRB for the current study. Patients must have the ability and willingness to comply with study procedures.
Exclusion Criteria:
* Ocular Health
* Any active or suspected ocular infection (bacterial, viral, fungal or protozoal).
* History of any ocular surgery (including laser or refractive surgical procedures) in the study eye within the 3 months prior to study enrollme…
What they're measuring
1
Improvement of Corneal Epithelial Barrier and/or Integrity (Efficacy Outcome)